Antibody/t-cell receptor chimeric constructs and uses thereof
US-2025361286-A1 · Nov 27, 2025 · US
This page is not indexed by search engines while we improve data quality.
Yan Su patents
Yan Su is listed as an inventor on 54 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Yan Su |
| Total patents | 54 |
| First publication | Jul 7, 2015 |
| Latest publication | Nov 27, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Antibody/T-cell receptor chimeric constructs and uses thereof
US-11976105-B2 · May 7, 2024 · US
Alpha-truxillic acid derivatives and pharmaceutical compositions thereof
US-2024092725-A1 · Mar 21, 2024 · US
Alpha-truxillic acid derivatives and pharmaceutical compositions thereof
US-11739047-B2 · Aug 29, 2023 · US
Anti-ROR2 antibodies
US-11673957-B2 · Jun 13, 2023 · US
Hybrid amide derivatives of amphotericin b
US-2023016424-A1 · Jan 19, 2023 · US
Antibody/t-cell receptor chimeric constructs and uses thereof
US-2022348629-A1 · Nov 3, 2022 · US
Antibody/T-cell receptor chimeric constructs and uses thereof
US-11421013-B2 · Aug 23, 2022 · US
Humanized antibodies to mucin-16 and methods of use thereof
US-2022235143-A1 · Jul 28, 2022 · US
T cell receptor-like antibodies specific for a PRAME peptide
US-11384144-B2 · Jul 12, 2022 · US
Recent patents
Latest publications not already listed above.
T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLA
US-11168150-B2 · Nov 9, 2021 · US
Anti-ROR1 antibodies
US-11155615-B2 · Oct 26, 2021 · US
Anti-KIR3DL1 antibodies
US-11117964-B2 · Sep 14, 2021 · US
Antibody/t-cell receptor chimeric constructs and uses thereof
US-2021253665-A1 · Aug 19, 2021 · US
Holistic document search
US-11093469-B2 · Aug 17, 2021 · US
Alpha-truxillic acid derivatives and pharmaceutical compositions thereof
US-2021179535-A1 · Jun 17, 2021 · US
T cell receptor-like antibodies specific for a wti peptide presented by hla-a2
US-2021163624-A1 · Jun 3, 2021 · US
Alpha-truxillic acid derivatives and pharmaceutical compositions thereof
US-10968163-B2 · Apr 6, 2021 · US
T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A2
US-10858444-B2 · Dec 8, 2020 · US
Antibody/T-cell receptor chimeric constructs and uses thereof
US-10822389-B2 · Nov 3, 2020 · US
Providing semantically relevant answers to questions
US-10789944-B2 · Sep 29, 2020 · US
T cell receptor-like antibody agents specific for ebv latent membrane protein 2a peptide presented by human hla
US-2020115470-A1 · Apr 16, 2020 · US
Antibody/t-cell receptor chimeric constructs and uses thereof
US-2020115434-A1 · Apr 16, 2020 · US
Unsupervised information extraction dictionary creation
US-10558747-B2 · Feb 11, 2020 · US
Unsupervised information extraction dictionary creation
US-10558756-B2 · Feb 11, 2020 · US
Anti-kir3dl1 antibodies
US-2020031927-A1 · Jan 30, 2020 · US
T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLA
US-10501559-B2 · Dec 10, 2019 · US
Providing semantically relevant answers to questions
US-2019371303-A1 · Dec 5, 2019 · US
Holistic document search
US-2019361856-A1 · Nov 28, 2019 · US
Antibody/T-cell receptor chimeric constructs and uses thereof
US-10464988-B2 · Nov 5, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Eureka Therapeutics Inc | 36 |
| Memorial Sloan Kettering Cancer Center | 19 |
| IBM | 10 |
| Univ New York State Res Found | 5 |
| Sloan Kettering Inst Cancer | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/622 | 36 |
| A61K2039/505 | 34 |
| C07K16/2809 | 32 |
| A61P35/00 | 30 |
| C07K2317/56 | 29 |